Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Cerebral, founded in 2019 and headquartered in Walnut, California, is a mental health company focused on improving access to treatment for anxiety and depression. The company offers video consultations with prescribing providers, medication delivery if prescribed, and ongoing support through assigned care managers. With a strong emphasis on telehealth services, Cerebral has positioned itself as a key player in the rapidly growing digital mental health sector.
Since its inception, Cerebral has demonstrated significant growth, raising a total of $462 million across multiple funding rounds. The company's most recent Series C funding round in December 2021 raised $300 million, valuing the company at $4.8 billion. This substantial valuation and the involvement of high-profile investors such as SoftBank and Access Industries highlight the market's confidence in Cerebral's business model and growth potential.
As of now, there is no concrete information available regarding Cerebral's plans for an initial public offering (IPO). The company has not made any official announcements about going public, and we have not found any credible reports or rumors suggesting an imminent IPO.
Several factors could influence Cerebral's decision to go public in the future, including market conditions, the company's financial performance, and its long-term growth strategy. The mental health industry has seen increased investor interest, particularly in digital health solutions, which could potentially create a favorable environment for an IPO. However, it's important to note that the decision to go public is complex and depends on various internal and external factors that are not publicly known at this time.
Investors interested in the mental health sector and potentially investing in Cerebral should continue to monitor the company's progress and any official announcements regarding its future plans. As always, it's crucial to conduct thorough research and consider the risks associated with investing in private companies before making any investment decisions.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Cerebral's IPO prospects remain uncertain, investors interested in the digital mental health space don't have to wait on the sidelines. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential industry leaders like Cerebral, with lower minimum investments than traditional private equity channels. This allows you to diversify your portfolio and potentially benefit from the growth of innovative healthcare technology companies before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
